4 ms·
if by close shop you mean, pay a token fine as the cost of doing business and move on, the yeah. if it were useful to big pharma to have that info, they’d have
by jiveturkey 6y ago
if by close shop you mean, pay a token fine as the cost of doing business and move on, the yeah.
if it were useful to big pharma to have that info, they’d have it.
- stef25 6y agoIt's not useful to them. And even if it was, they'd be breaking half a dozen rules at the risk of getting the whole study trashed and billions lost, for almost no benefit. Getting a study invalidated is the nightmare scenario of every pharma company. And it's not just the FDA or EMEA but also scientific journals that go through this stuff.